Perkovic V, et al
In fact, one recent propensity-matched analysis of non-diabetic patients found that GLP-1 use was associated with a lower incidence of UTI, 8.8% compared to 13.3% in the control group
Receptors for GLP-1 are present in various cell types such as pancreatic, endothelial and myocardial cells
How to keep the weight off after GLP-1 medications: Lifestyle changes When you stop a GLP-1 medication, your appetite hormones begin shifting back toward their natural baseline
A Cochrane systematic review of NAC for COPD exacerbations (39 RCTs, n=7,436) found that NAC and other mucolytics significantly reduced the frequency of acute exacerbations (OR 0.75, 95% CI 0.62-0.92) (Poole et al., Cochrane Database Syst Rev, 2019) [43]
Diabetes Obes Metab 2021;23:18-28